2021FYfalse000163307000016330702021-01-012021-12-3100016330702021-06-30iso4217:USD00016330702022-03-28xbrli:shar...
0001633070FALSE840 Memorial DriveCambridgeMassachusetts00016330702022-03-302022-03-30UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington...
Completed $25 million registered direct stock offering priced at the market Initiated Phase 2a Long COVID clinical trial Fast Track designation...
Conference call to take place at 8:30 a.m. ET Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
0001633070 false 0001633070 2022-03-16 2022-03-16 iso4217:USD xbrli:shares...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE...
Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using...
TABLE OF CONTENTS Filed Pursuant to Rule 424(b)(5) Registration No...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.